[Effects of hormonal contraception on benign changes of the breast].
D000232:Adenofibroma / Q000139:chemically induced*; D000236:Adenoma / Q000139:chemically induced*; D000328:Adult; D001941:Breast Diseases / Q000139:chemically induced*; D001943:Breast Neoplasms / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D003560:Cysts / Q000139:chemically induced*; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D008875:Middle Aged; D009644:Norgestrel / Q000009:adverse effects
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D009644:Norgestrel; D016912:Levonorgestrel
Effetti della contraccezione ormonale sulle alterazioni benigne della mammella.